论文部分内容阅读
目的分析孟鲁司特钠在儿科哮喘治疗中的临床应用疗效。方法选自我院2015年4月~2016年4月收治的哮喘患儿100例作为研究对象,根据治疗的先后顺序分为常规组与孟鲁司特纳组,常规组患儿为50例,采取抗感染、痉挛平喘治疗,孟鲁司特纳组患儿50例采用孟鲁司特纳治疗,对比孟鲁司特纳组与常规组的疗效。结果孟鲁司特纳组与常规组患儿的病症均得到缓解,但与常规组相比,孟鲁司特纳组的治疗更为显著,孟鲁司特纳组患儿的咳嗽次数、咳嗽频率明显降低。比较孟鲁司特纳组与常规组患儿的症状改善率、不良反应、症状好转时间和治疗时间,差异有统计学意义(P<0.05)。结论对哮喘患儿采用辅助孟鲁司特纳治疗,其临床疗效十分显著,降低了患儿白天和夜间咳嗽频率,门诊治疗时间和症状好转时间缩短,提高了哮喘患儿的生活质量。且孟鲁司特纳安全性高,可以放心运用于小儿哮喘的临床治疗中,临床上值得推广。
Objective To analyze the clinical effect of montelukast sodium in the treatment of pediatric asthma. Methods 100 children with asthma admitted from April 2015 to April 2016 in our hospital were divided into routine group and montelukastane group according to the order of treatment, 50 children in routine group Anti-infective, spasmodic asthma treatment, montelukastatin group of 50 patients treated with montelukastin, montelukastone group compared with the conventional treatment group. Results The patients in montelukastina group and normal group were relieved of their symptoms, but the treatment with montelukastina was more significant than that in the conventional group. The frequency of cough, cough The frequency is significantly reduced. The improvement rate, adverse reactions, symptom improvement time and treatment time between the montelukastane group and the routine group were statistically significant (P <0.05). Conclusions The use of adjunctive montelukastone in children with asthma has a significant clinical effect, reducing the frequency of cough during daytime and nighttime, reducing the time for outpatient treatment and improving symptoms, and improving the quality of life of children with asthma. And Montelukast Turner high security, can be safely used in the clinical treatment of pediatric asthma, clinically worth promoting.